A male patient younger than 50 is home recovering after being treated for what hospital officials suspect was a severe, rare clot event linked to the Johnson and Johnson COVID-19 vaccine.
A male patient younger than 50 is home recovering after being treated for what hospital officials suspect was a severe, rare clot event linked to the Johnson and Johnson COVID-19 vaccine.
